CGA
HURA

Crescent Grove Advisors’s TuHURA Biosciences HURA Stock Holding History

Crescent Grove Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3
Closed -$47K – 151
2018
Q1 		$47K Buy
3
+1
+50% +$21.9K 0.01% 144
2017
Q4 		$29K Hold
2
– – 0.01% 144
2017
Q3 		$23K Buy
+2
New +$54.8K 0.01% 141

Other funds holding HURA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Crescent Grove Advisors's HURA Position: Q2 2018 in Review

Crescent Grove Advisors sold out of TuHURA Biosciences (HURA) in Q2 2018, closing a stake of 3 shares — an estimated $47K sold.

Crescent Grove Advisors first reported a position in HURA in Q3 2017 and held it in 3 quarters. The position peaked at $47K in Q1 2018. 7 funds tracked by Wall St. Rank hold HURA as of Q2 2018.

  • Crescent Grove Advisors reported no remaining TuHURA Biosciences position as of Q2 2018 after selling out during the quarter.
  • Crescent Grove Advisors sold 3 TuHURA Biosciences shares in Q2 2018, an estimated $47K.
  • Crescent Grove Advisors first reported a position in TuHURA Biosciences in Q3 2017 and held it in 3 quarters.
  • Crescent Grove Advisors's TuHURA Biosciences position peaked at $47K in Q1 2018.
  • 7 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2018.

Based on Crescent Grove Advisors's 13F filing for Q2 2018, filed 16 Jul 2018.